Abrogated cryptic activation of lentiviral transfer vectors

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Luche, Ralf M ^a   Enssle, Joerg ^a   Kiem, Hans Peter ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; PHOTOPROTEIN; RED FLUORESCENT PROTEIN;

ARTICLE; CELL STRAIN HEK293; FLOW CYTOMETRY; GENE DELETION; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; LENTIVIRINAE; METABOLISM; METHODOLOGY; TUMOR CELL LINE; VIRUS ASSEMBLY; VIRUS GENE;

CELL LINE, TUMOR; FLOW CYTOMETRY; GENE DELETION; GENES, VIRAL; GENETIC THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HUMANS; LENTIVIRUS; LUMINESCENT PROTEINS; TRANSDUCTION, GENETIC; VIRUS ASSEMBLY;

EID: 84861879846     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00438     Document Type: Article

References (29)

1. Naldini, L. Medicine. A comeback for gene therapy. Science 326, 805-806 (2009).
2. Naldini, L. Ex vivo gene transfer and correction for cell-based therapies (Review). Nat Rev Genet 12, 301-315 (2011).
3. Yi, Y., Noh, M. J. & Lee, K. H. Current advances in retroviral gene therapy (Review). Current Gene Therapy 11, 218-228 (2011).
4. Kappes, J. C. & Wu, X. Safety considerations in vector development (Review). Somat.Cell.Mol.Genet. 26, 147-158 (2001).
5. Cockrell, A. S. & Kafri, T. Gene delivery by lentivirus vectors (Review). Molecular Biotechnology 36, 184-204 (2007). (Pubitemid 350135911)
6. Logan, A. C., Haas, D. L., Kafri, T. & Kohn, D. B. Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration. J.Virol. 78, 8421-8436 (2004). (Pubitemid 39025108)
7. Cornetta, K. et al. Replication-competent lentivirus analysis of clinical grade vector products. Mol Ther 19, 557-566 (2011).
8. Evans, J. T. & Garcia, J. V. Lentivirus vector mobilization and spread by human immunodeficiency virus. Hum.Gene Ther. 11, 2331-2339 (2000).
9. Chong, H., Starkey, W. & Vile, R. G. A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences. J.Virol. 72, 2663-2670 (1998). (Pubitemid 28175500)
10. Connolly, J. B. Lentiviruses in gene therapy clinical research. Gene Ther. 9, 1730-1734 (2002).
11. Gossen, M. & Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc.Natl.Acad.Sci.USA 89, 5547-5551 (1992).
12. Gossen, M. et al. Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769 (1995).
13. Schmidt, M. et al. High-resolution insertion-site analysis by linear amplificationmediated PCR (LAM-PCR). Nature Methods 4, 1051-1057 (2007). (Pubitemid 350201778)
14. Louis, N., Evelegh, C.&Graham, F. L. Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line. Virology 233, 423-429 (1997). (Pubitemid 27314828)
15. Dull, T. et al. A third-generation lentivirus vector with a conditional packaging system. J.Virol. 72, 8463-8471 (1998). (Pubitemid 28471781)
16. Zavada, J. Viral pseudotypes and phenotypic mixing (Review). Archives of Virology 50, 1-15 (1976).
17. Sorrentino, B. P. Clinical strategies for expansion of haematopoietic stem cells (Review). Nat Rev Immunol 4, 878-888 (2004). (Pubitemid 39490763)
18. Zhang, X.-B. et al.High incidence of leukemia in large animals after stem cell gene therapy with a HOXB4-expressing retroviral vector. J.Clin.Invest. 118, 1502-1510 (2008). (Pubitemid 351500443)
19. Larochelle, A. & Dunbar, C. E. HOXB4 and retroviral vectors: adding fuel to the fire. J.Clin.Invest. 118, 1350-1353 (2008). (Pubitemid 351500428)
20. Richardson, J. H., Child, L. A. & Lever, A. M. Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 59 leader region. J.Virol. 67, 3997-4005 (1993). (Pubitemid 23180724)
21. Berkowitz, R. D., Hammarskjold, M. L., Helga-Maria, C., Rekosh, D. & Goff, S. P. 59 regions of HIV-1 RNAs are not sufficient for encapsidation: implications for the HIV-1 packaging signal. Virology 212, 718-723 (1995).
22. Lu, K., Heng, X. & Summers, M. F. Structural determinants and mechanism of HIV-1 genome packaging (Review). J.Mol.Biol. 410, 609-633 (2011).
23. Van Deursen, J., Fornerod, M., Van Rees, B. & Grosveld, G. Cre-mediated sitespecific translocation between nonhomologous mouse chromosomes. Proc.Natl.Acad.Sci.USA 92, 7376-7380 (1995).
24. Smith, A. J. et al. A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination [Erratum appears in Nat Genet 1996 Jan;12(1):110]. Nat.Genet. 9, 376-385 (1995).
25. Weber, K., Bartsch, U., Stocking, C. & Fehse, B. A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis. Mol Ther 16, 698-706 (2008). (Pubitemid 351426171)
26. He, T. C. et al. A simplified system for generating recombinant adenoviruses. PNAS 95, 2509-2514 (1998).
27. DuBridge, R. B. et al. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol.Cell.Biol. 7, 379-387 (1987).
28. Rasheed, S., Nelson-Rees, W. A., Toth, E. M., Arnstein, P. & Gardner, M. B. Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33, 1027-1033 (1974).
29. Beagles, K. E., Peterson, L., Zhang, X., Morris, J. & Kiem, H.-P. Cyclosporine inhibits the development of green fluorescent protein (GFP)-specific immune responses after transplantation of GFP-expressing hematopoietic repopulating cells in dogs. Hum.Gene Ther. 16, 725-733 (2005). (Pubitemid 40864272)